Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Colorcon
AstraZeneca
McKesson
Medtronic

Last Updated: September 25, 2022

CLOBETASOL PROPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


When do Clobetasol Propionate patents expire, and when can generic versions of Clobetasol Propionate launch?

Clobetasol Propionate is a drug marketed by Aleor Dermaceuticals, Glenmark Pharms Ltd, Ingenus Pharms Llc, Padagis Israel, Taro, Amneal, Aurobindo Pharma Usa, Cosette, Encube, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Pai Holdings Pharm, Rising, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Padagis Us, Actavis Mid Atlantic, Akorn, Cadila, Novel Labs Inc, Taro Pharms, Macleods Pharms Ltd, Prinston Inc, Saptalis Pharms, Solaris Pharma Corp, Wockhardt Bio Ag, Apotex, and Ani Pharms. and is included in seventy-eight NDAs.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Clobetasol Propionate

A generic version of CLOBETASOL PROPIONATE was approved as clobetasol propionate by COSETTE on February 16th, 1994.

  Try it Free

Drug patent expirations by year for CLOBETASOL PROPIONATE
Drug Prices for CLOBETASOL PROPIONATE

See drug prices for CLOBETASOL PROPIONATE

Drug Sales Revenue Trends for CLOBETASOL PROPIONATE

See drug sales revenues for CLOBETASOL PROPIONATE

Recent Clinical Trials for CLOBETASOL PROPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
FundaciĆ³n Eduardo AnituaPhase 3
TC Erciyes UniversityPhase 1
Monitor CROPhase 1

See all CLOBETASOL PROPIONATE clinical trials

Pharmacology for CLOBETASOL PROPIONATE
Medical Subject Heading (MeSH) Categories for CLOBETASOL PROPIONATE
Paragraph IV (Patent) Challenges for CLOBETASOL PROPIONATE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
IMPOYZ Cream clobetasol propionate 0.025% 209483 1 2019-12-06
OLUX E Emulsion Foam clobetasol propionate 0.05% 022013 1 2010-02-25
CLOBEX Spray clobetasol propionate 0.05% 021835 1 2008-09-29
CLOBEX Topical Shampoo clobetasol propionate 0.05% 021644 1 2008-01-09
CLOBEX Lotion clobetasol propionate 0.05% 021535 1 2006-03-27
OLUX Topical Foam clobetasol propionate 0.05% 021142 1 2005-06-27

US Patents and Regulatory Information for CLOBETASOL PROPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us CLOBETASOL PROPIONATE clobetasol propionate SPRAY;TOPICAL 090898-001 Jun 16, 2011 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Glenmark Pharms CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 208933-001 Mar 20, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Pai Holdings Pharm CLOBETASOL PROPIONATE clobetasol propionate LOTION;TOPICAL 208667-001 Nov 29, 2016 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Akorn CLOBETASOL PROPIONATE clobetasol propionate SHAMPOO;TOPICAL 209871-001 Oct 27, 2017 AB RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Novel Labs Inc CLOBETASOL PROPIONATE clobetasol propionate SOLUTION;TOPICAL 206075-001 Nov 23, 2015 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Torrent CLOBETASOL PROPIONATE clobetasol propionate OINTMENT;TOPICAL 212926-001 Oct 25, 2019 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Harvard Business School
Boehringer Ingelheim
Baxter
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.